Guidelines for Radiotherapy of Esophageal Carcinoma (2020 Edition): Branch of Radiation Oncology Therapists, Chinese Medical Association; Society of Radiation Oncology Therapy, Chinese Medical Association; Cancer Radiotherapy Committee of China Anti-Cancer Association

Precision Radiation Oncology

article

Heyi Gong¹  Baosheng Li¹ 

[1] Shandong Cancer Hospital

关键词: clinical guidelines;    esophageal neoplasms;    radiotherapy;    Unless otherwise noted;    all are class 2A recommendations;   

DOI  :  10.1002/pro6.1119

学科分类：社会科学、人文和艺术（综合）

来源: Wiley

【 摘 要 】

Esophageal carcinoma is a high-incidence malignant tumor in China,ranking sixth and fourth highest in morbidity and mortality, respectively. Radiotherapy plays an important role in the comprehensivetreatment of esophageal carcinoma. Standardized diagnosis and treatment based on the suggestions of a multidisciplinary team (MDT)form its foundation. For operable esophageal carcinoma, surgery afterneoadjuvant chemoradiotherapy is the standard treatment; contrarily,for inoperable esophageal carcinoma, radical chemoradiotherapy is theonly treatment option, and postoperative adjuvant radiotherapy canimprove local control and survival rates in selected cases. Owing to therapid technological development in radiotherapy, three-dimensionalconformal radiotherapy, intensity-modulated radiotherapy, and imageguidance technology are widely used in the treatment of esophagealcarcinoma. Though drugs for treating cancer have been developedrapidly, we need to explore their optimal combination with radiotherapy, including chemotherapy, targeted or immune, and radiosensitizers.Esophageal carcinoma in China differs greatly from that in Europeanand American countries in terms of etiology, pathological type, highincidence site, etc. Therefore, the European and American guidelineson radiotherapy for esophageal carcinoma cannot be applied in clinical practice in China.

【 授权许可】

CC BY|CC BY-NC|CC BY-NC-ND